Ofatumumab in previously untreated chronic lymphocytic leukaemia. No clear advantages when added to chlorambucil.
View on PubMed
Abstract & Figures
In a trial including 447 leukaemia patients in whom fludarabine was unsuitable, adding ofatumumabto chlorambucil prolonged time to disease progression or death but did not reduce overall mortality. Adverse effects were more numerous.
Chronic Lymphocytic Leukemia
Cessation of life
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics